期刊文献+

法舒地尔抑制醛固酮对单侧肾切除大鼠的肾损伤作用 被引量:2

Suppressive effect of fasudil on aldosterone-induced renal injury in uninephrectomized rats
原文传递
导出
摘要 目的观察Rho/Rho激酶通路是否参与醛固酮加氯化钠诱导的肾脏损伤并探讨可能的机制。方法把单肾切除、进饮1%氯化钠的SD大鼠随机分为3组:对照组(2%乙醇皮下泵入)、醛固酮组(2%乙醇+醛固酮0.75μg/h皮下泵入)和醛固酮+法舒地尔(fasudil)组(2%乙醇+醛固酮0.75μg/h皮下泵入+fasudil 10 mg·kg^-1·d^-1皮下注射)。5周后,检测3组大鼠血压、尿蛋白改变;PAS染色和Masson三染法观察肾脏组织学变化;放射免疫方法检测肾皮质血管紧张素Ⅱ(AngⅡ)水平;Western印迹法检测血管紧张素转化酶(ACE)、磷酸化(p)RhoA及p-MYPT1水平;实时定量PCR检测转化生长因子β1(TGF-β1)及胶原Ⅰ、ⅢmRNA表达。结果与对照组比较,醛固酮诱发了严重的高血压[(193±3)mm Hg比(130±4)mm Hg,P〈0.05]、大量尿蛋白量(24 h)[(362±93)mg比(22±3)mg,P〈0.05]及肾小球、肾小管间质损伤,同时伴随肾皮质AngⅡ水平[(154±16)pmol/g比(81±8)pmol/g,P〈0.05]及ACE表达增高,RhoA及Rho激酶活性增强,肾皮质TGF-β1、胶原Ⅰ、胶原ⅢmRNA表达增加。而fasudil在抑制Rho激酶活性的同时,在没有影响血压的情况下,显著减少了尿蛋白量(24 h)[(96±22) mg],减轻了肾小球及肾小管间质损伤,并且减少了肾皮质TGF-β1、胶原Ⅰ、胶原ⅢmRNA表达。但肾内AngⅡ水平[(148±11)pmol/g]、ACE及RhoA表达无改变。结论Rho/Rho激酶通路参与了醛固酮加氯化钠诱导的肾损伤。fasudil对醛固酮加氯化钠肾脏损伤的保护作用并非通过抑制肾内ACE过表达及AngⅡ增多而实现。 Objective To investigate whether Rho/Rho kinase is involved in the pathogenesis of aldosterone/salt-induced renal injury. Methods Twenty-six uninephrectomized rats which were limited to drink only 1% sodium chloride were divided randomly into three groups: control [2% ethanol, subcutaneous (SC)], aldosterone (0.75μg/h aldosterone, SC) and aldosterone (0.75μg/h aldosterone, SC) plus fasudil(10 mg·kg^-1·d^-1, SC). After treatment for 5 weeks, systolic blood pressure, proteinuria, renal histological examination, angiotensin Ⅱ level, expression of phospho-RhoA, phospho-MYPT1 (represent Rho kinase activity) and ACE by Western blot and mRNA expression of TGF-β1, collagen Ⅰ and collagen Ⅲ by real-time PCR were all tested. Results Aldosterone plus salt induced severe hypertension[( 193±3 ) mm Hg vs. (130±4) mm Hg, P〈0.05], mass proteinuria[(362±93) mg/24 h vs. (22±3) mg/24 h, P〈0.05] and severe glomerular proliferative lesion and tubular interstitial fibrosis, accompanied by augmented angiotensin Ⅱ level [(154±16) pmol/g vs. (81±8) pmol/g, P〈0.05)] and increased expression of phospho-RhoA and phospho-MYPT1, as well as TGF-β1, collagen Ⅰ and collagen Ⅲ mRNA in the cortex. But fasudil, a kind of Rho-kinase inhibitor, significantly ameliorated the above effects without changes of angiotensin Ⅱ level, ACE and phospho-RhoA expression and systolic blood pressure. Conclusions Increased cortical Rho/Rho-kinase is involved in aldosterone-induced renal injury. The renoprotection of fasudil is not carried out via suppressing increased cortical angiotensin Ⅱ level and ACE overexpression.
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2007年第12期800-805,共6页 Chinese Journal of Nephrology
关键词 醛固酮 血管紧张素Ⅱ RHO因子 RHO激酶 肾损伤 Aldosterone Angiotensin Ⅱ Rho factor Rho kinase Renal injury
作者简介 通讯作者:张锦,Email:zhangjininsy@gmail.com
  • 相关文献

参考文献25

  • 1Nishiyama A, Yao L, Fan Y, et al. Involvement of aldosterone and mineralocorticoid receptors in rat mesangial cell proliferation and deformability. Hypertension, 2005, 45: 710-716.
  • 2Nagai Y, Miyata K, Sun GP, et al. Aldosterone stimulates collagen gene expression and synthesis via activation of ERK1/2 in rat renal fibroblasts. Hypertension, 2005, 46: 1039-1045.
  • 3Sun GP, Kohno M, Guo P, et al. Involvement of Rho-kinase and TGF-13 pathway in aldosterone-induced renal injury. J Am Soc Nephrol, 2006, 17: 2193-2201.
  • 4Fan YY, Baba R, Nagai Y, et al. Augmentation of intrarenal angiotensin II levels in uninephrectomized aldosterone/salt-t reated hypertensive rats; renoprotective effects of an ultrahigh dose of olmesartan. Hypertens Res, 2006, 29: 169-178.
  • 5Kobayashi N, Nakano S, Mita S, et al. Involvement of Rhokinase pathway for angiotensin II-induced plasminogen activator inhibitor- 1 gene expression and cardiovascular remodeling in hypertensive rats. J Pharmacol Exp Ther, 2002, 301: 459-466.
  • 6Zou LX, Hymel A, Imig JD, et al. Renal accumulation of circulating angiotensin II in angiotensin II-infused rats. Hypertension, 1996, 27: 658-662.
  • 7Li C, Yang CW, Park CW, et al. Long-term treatment with ramipril attenuates renal osteopontin expression in diabetic rats. Kidney Int, 2003, 63: 454-463.
  • 8Shihab FS.Andoh TF,Tanner AM,et al.Expression of apoptosis regulatory genes in chronic cyclosporine nephrotoxicity favors apoptosis.Kidney Int,1999,56:2147-2159.
  • 9Shimada T, Yasuda K, Moil A, et al. Aldosterone binding to mineralocorticoid receptors of mononuclear leukocytes in diabetic subjects. Acta Endocrinol (Copenh), 1993, 128: 529- 535.
  • 10Fiebeler A, Hailer H. Participation of mineraiocorticoid receptor in cardiac and vascular remodling. Nephron Physiol, 2003, 94: P47-P50.

二级参考文献2

共引文献40

同被引文献17

  • 1韩敏,徐钢,曾锐,刘蔚.β-连环素酪氨酸磷酸化调控E-钙黏蛋白表达参与转化生长因子β1诱导的人肾小管上皮细胞转分化[J].中华肾脏病杂志,2006,22(8):494-498. 被引量:21
  • 2Zeisberg M, Kalluri R. The role of epithelial-to-mesenchymal transition in renal fibrosis. J Mol Med, 2004, 82: 175-181.
  • 3Masszi A, Di Ciano C, Sirokmany G, et al. Central role for Rho in TGF-betal -induced alpha-smooth muscle actin expression during epithelial-mesenchymal transition. Am J Physiol Renal Physiol, 2003, 284: F911-F924.
  • 4Prakash J, de Borst MH, Lacombe M, et al. Inhibition of renal rho kinase attenuates ischemia/reperfusion-induced injury. J Am Soc Nephrol, 2005, 19: 2086-2097.
  • 5Bach LA. Rho kinase inhibition: a new approach for treating diabetic nepbropathy? Diabetes, 2008, 57: 532-533.
  • 6Kolavennu V, Zeng LX, Peng H, et al. Targeting of RhoA/ ROCK signaling ameliorates progression of diabetic nephropathy independent of glucose control. Diabetes, 2008, 57: 714-723.
  • 7Peng F, Wu D, Gao B, et al. RhoA/Rho-kinase contribute to the pathogenesis of diabetic renal disease. Diabetes, 2008, 57:1683-1692.
  • 8Ishibashi F. High glucose increases phosphocofilin via phosphorylation of LIM kinase due to Rho/Rho kinase activation in cultured pig proximal tubular epithelial cells. Diabetes Res Clin Pract, 2008, 80: 24-33.
  • 9Ina K, Kitamura H, Tatsukawa S, et al. Contraction of tubulointerstitial fibrosis tissue in diabetic nephropathy, as demonstrated in an in vitro fibrosis model. Virchows Arch, 2007, 451: 911-921.
  • 10Wettschureck N, Offermanns S. Rho/Rho-kinase mediated signaling in physiology and pathophysiology. J Mol Med, 2002, 80: 629-638.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部